Idaho Strategic Resources (NYSEAMERICAN:IDR – Get Free Report) announced its quarterly earnings data on Monday. The company reported €0.15 ($0.16) EPS for the quarter, missing analysts’ consensus estimates of €0.21 ($0.23) by (€0.06) (($0.07)), Zacks reports. The firm had revenue of €6.15 million during the quarter, compared to the consensus estimate of €7.40 million. Idaho Strategic Resources had a net margin of 26.69% and a return on equity of 22.07%.
Idaho Strategic Resources Trading Up 4.0 %
Shares of IDR opened at €13.93 ($15.31) on Wednesday. Idaho Strategic Resources has a 52 week low of €4.75 ($5.22) and a 52 week high of €18.35 ($20.16). The company has a debt-to-equity ratio of 0.07, a quick ratio of 5.58 and a current ratio of 6.01. The firm has a market capitalization of $180.53 million, a price-to-earnings ratio of 35.72 and a beta of 0.81.
Analyst Ratings Changes
Separately, Roth Mkm increased their price objective on Idaho Strategic Resources from $10.00 to $14.00 and gave the company a “buy” rating in a research report on Monday, August 26th.
About Idaho Strategic Resources
Idaho Strategic Resources, Inc, a resource-based company, engages in exploring for, developing, and extracting gold, silver, and base metal mineral resources in the Greater Coeur d'Alene Mining District of North Idaho. Its portfolio of mineral properties includes the Golden Chest Mine, a producing gold mine located in the Murray Gold Belt (MGB) of North Idaho; approximately 1,500 acres of patented mineral property and approximately 5,000 acres of nearby and adjacent un-patented mineral property located within the MGB; rare earth element projects located in the Idaho REE-Th Belt near Salmon, Idaho; and early-stage exploration properties in Central Idaho.
Featured Stories
- Five stocks we like better than Idaho Strategic Resources
- How to buy stock: A step-by-step guide for beginners
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
- How to Use the MarketBeat Dividend Calculator
- Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?
Receive News & Ratings for Idaho Strategic Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idaho Strategic Resources and related companies with MarketBeat.com's FREE daily email newsletter.